StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.96+0.07 (+3.70%)

Close on Nov 17, 2026Market cap $18.90MP/E –Yield –

Edesa Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Edesa Biotech's profit margin for the twelve months ending Jun 30, 2021 was -2334161.4%. For fiscal 2020 it was -1935.3%, against -2378.6% the year before. The highest annual figure on record is -395.2% in fiscal 2016.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Sep 30, 2020-1935.3%+443.2
FY2018Sep 30, 2018-2378.6%−174.9
FY2017Sep 30, 2017-2203.7%−1808.4
FY2016Sep 30, 2016-395.2%+1872.7
FY2014Aug 31, 2014-2267.9%+389.6
FY2013Aug 31, 2013-2657.5%−724.5
FY2012Aug 31, 2012-1932.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2020CQ3 2020Sep 30, 2020-402739.6%−143938.2
Q3 FY2020CQ2 2020Jun 30, 2020-1605.5%+475.4
Q2 FY2020CQ1 2020Mar 31, 2020-1347.9%+763.7
Q1 FY2020CQ4 2019Dec 31, 2019-1015.2%+5822.1
Q3 FY2019CQ2 2019Jun 30, 2019-258801.4%−216407.7
Q4 FY2018CQ3 2018Sep 30, 2018-2080.8%+3862.9
Q2 FY2018CQ1 2018Mar 31, 2018-2111.6%−360.3
Q1 FY2018CQ4 2017Dec 31, 2017-6837.2%−5789.9
Q4 FY2017CQ3 2017Sep 30, 2017-42393.7%−41907.9
Q3 FY2017CQ2 2017Jun 30, 2017-5943.7%–
Q2 FY2017CQ1 2017Mar 31, 2017-1751.3%–
Q1 FY2017CQ4 2016Dec 31, 2016-1047.3%–
Q4 FY2016CQ3 2016Sep 30, 2016-485.8%–

More Edesa Biotech figures

See a number that looks wrong?